Our website uses cookies to improve your on-site experience. By using the website, cookies are being used as described in our Policy Document
Warning: To log in you will need to enable cookies and reload the page (Policy Document)
My ePortfolio Register   

EACR 2016 /
DNA repair and mutations as targets for personalised therapy

9th - 12th Jul 2016

Please rate this video

Please complete at least one question.

  1. The information in this video was of interest to me Disagree Agree
  2. The information in this video is likely to improve my clinical practice or research Disagree Agree
  3. I would recommend this video to my colleagues Disagree Agree
Thanks for rating
There has been a problem, please refresh and try again.
Published: 15.07.16
Views: 2099

Prof Zoltan Szallasi - Boston Children's Hospital, Boston, USA

Prof Szallasi speaks with ecancertv at EACR 2016 about disrupted DNA repair pathways in cancer that may be targeted by therapy.

He summarises the mechanism of DNA repair in healthy and mutated cells and his work with next-generation sequencing of biopsy samples to uncover the origins of disease states, and how this can inform treatment selection.

With specific example of BRCA mutations, Prof Szallasi considers how genomic data are part of personalised therapy, and can contribute to new drug discovery.

Previous conferences: highlights

Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

ecancer Global Foundation